DIFFERENCES OF ANGIOTENSIN RECEPTOR BLOCKERS THERAPY ASSOCIATED TO MINERALOCORTICOID RECEPTOR ANTAGONISTS OR CALCIUM CHANNEL BLOCKERS ACCORDING TO CENTRAL HAEMODYNAMIC PARAMETERS

被引：0
|
作者：
Paterno, C. A.
机构：
来源：
JOURNAL OF HYPERTENSION | 2019年 / 37卷
关键词：
D O I：
10.1097/01.hjh.0000572208.94598.c9
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E172 / E173
页数：2
相关论文
共 50 条
  • [31] A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity
    Dietz, Jessica D.
    Du, Sarah
    Bolten, Charles W.
    Payne, Maria A.
    Xia, Chunsheng
    Blinn, James R.
    Funder, John W.
    Hu, Xiao
    HYPERTENSION, 2008, 51 (03) : 742 - 748
  • [32] New aspect of calcium channel blockers: How azelnidipine inhibits mineralocorticoid receptor activity
    Kawarazaki, Wakako
    Nagase, Miki
    Ishizawa, Kenichi
    Takeuchi, Maki
    Yoshida, Shigetaka
    Shibata, Shigeru
    Fujita, Toshiro
    ENDOCRINE JOURNAL, 2010, 57 : S544 - S544
  • [33] Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or beta-blockers for treating hypertension
    Bisognano, John D.
    McLaughlin, Trent
    Roberts, Craig S.
    Tang, Simon S. K.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (05) : 579 - 585
  • [34] Angiotensin receptor blockers therapy and cancer risk
    Lai, Shih-Wei
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 72 : 108 - 108
  • [35] HYDROCHLOROTHIAZIDE ASSOCIATED TO ANGIOTENSIN RECEPTOR BLOCKERS TREATMENT CAN DEVELOP ATRIAL FIBRILLATION ACCORDING CENTRAL HEAMODYNAMIC PARAMETERS IN HYPERTENSIVE PATIENTS
    Marchioli, C. A. Paterno
    JOURNAL OF HYPERTENSION, 2018, 36 : E161 - E161
  • [36] Angiotensin receptor blockers: baseline therapy in hypertension?
    Messerli, Franz H.
    Bangalore, Sripal
    Ruschitzka, Frank
    EUROPEAN HEART JOURNAL, 2009, 30 (20) : 2427 - 2430
  • [37] Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers
    Mehlum, Maria H.
    Liestol, Knut
    Kjeldsen, Sverre E.
    Wyller, Torgeir B.
    Julius, Stevo
    Rothwell, Peter M.
    Mancia, Giuseppe
    Parati, Gianfranco
    Weber, Michael A.
    Berge, Eivind
    HYPERTENSION, 2020, 75 (06) : 1584 - 1592
  • [38] Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
    Nishida, Yayoi
    Takahashi, Yasuo
    Nakayama, Tomohiro
    Asai, Satoshi
    CARDIOVASCULAR DIABETOLOGY, 2012, 11
  • [39] Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
    Nishida, Yayoi
    Takahashi, Yasuo
    Asai, Satoshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 207P - 207P
  • [40] Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
    Yayoi Nishida
    Yasuo Takahashi
    Tomohiro Nakayama
    Satoshi Asai
    Cardiovascular Diabetology, 11
12345